Drug Type Small molecule drug |
Synonyms Bazedoxifene Acetate/Colecalciferol, Bazedoxifene/Cholecalciferol, 醋酸巴多昔芬/胆骨化醇 + [7] |
Target |
Mechanism ERα agonists(Estrogen receptor alpha agonists), ERβ agonists(Estrogen receptor beta agonists), VDR agonists(Vitamin D receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Molecular FormulaC32H38N2O5 |
InChIKeyOMZAMQFQZMUNTP-UHFFFAOYSA-N |
CAS Registry198481-33-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoporosis | Phase 1 | KR | 16 Oct 2017 |